Today in Medicine

Innovational, futuristic, sustainable, environmentally safe, Executive Grade is the new leather class. and holds a variety of remarkable characteristics

AMSTERDAM, AMSTERDAM, NETHERLANDS, October 17, 2021 /EINPresswire.com/ — In the 21st century, leather is trendy in fashion. However, this modern fabric cannot be adequately washed, and the ongoing sanitary crisis puts leather in a position as a carrier to spread bacterias, germs, and viruses.
Today, Dutch company Undercolor BV is launching the advanced leather Executive Grade, as the the new upgraded leather class, a historic improvement that significantly impacts our society. This is the only leather approved for automatic machine wash with detergent at medium-high temperature, and it does not require maintenance. Even more, the breathable feature and stretchable option elevate Executive Grade as the new age for elastic and upcoming trendy fabric for lingerie and sports fashion; lining is not required.
Innovational, futuristic, sustainable, environmentally safe, Executive Grade is produced by tanning raw hides with a secret formula of vegetable extracts and zero chemicals.
“This new machine washable leather is produced in 25-40 days, while 90% of the leather produced globally is processed in one day using Chromium salts; extremely harmful to the ecosystem, workers, regions where factories are located, and of course the end consumer of this cheap leather” says the CEO of the company Eliot Paus
The Executive Grade characteristics are remarkable:
– Leather with full-grain and rawhides sourced from sheep, goat, cow or buffalo
– Leather machine washable with detergent at temperature up to 40 degrees Celsius / 104 Fahrenheit
– Executive Grade does not require maintenance; contact with body oils will feed the leather.
– Non-allergenic properties
– It can be ironed with a cloth over the leather as protection against the heat, but without steaming
– Thinnest leather up to 0,3 mm, maintaining high strength
– Up to 3 times elasticity and breathable option
– Matte or glossy finishing
– Any texture, colour, print or embossing
– Abrasion resistant
– All seasons leather, even for the hottest summer, fthis leather is ideal to protect from the sun heat, without sweating
– Does not require linen or another impeachment
– Proven safe for lingerie and sports fashion
– Safe for the environment, production process 100% with vegetable extracts and sustainable, with raw hides sourced from the meat industry
– With all the above features, it can also be produced with waterproof attributes.
– High quality assured with the warranty of 3 years.
“Our departments work in close coordination with each other. All of them contribute their expertise. The leather is designed in Amsterdam where is also located the trading company, and it come to life in our tannery. In India, the leather factory commands a 4th generation family business. The tannery produces washable leather exclusively for our Dutch company and has a large production capacity up to half a million square feet monthly. The time leading production for the Executive Grade is a long process, but we always have a large amount ready for fast finishing” says Eliot Paus, the CEO of Undercolor BV, exclusive owner of this leather class

PR Executive Grade
UNDERCOLOR B.V.
email us here
Visit us on social media:
Facebook

Executive Grade, first leather approved for automatic machine wash with detergent, does not require maintenance

Source: EIN Presswire

Diagu solution offers unprecedented speed, accuracy, and context to situations where every second counts and accurate diagnoses are absolutely critical.

SAN DIEGO, CA, USA, October 17, 2021 /EINPresswire.com/ — How to Improve Hospitals’ Operational Efficiency? Support Better Diagnoses

A new tool promises to help doctors make quicker, more accurate diagnoses by enhancing the reports they receive from testing laboratories. What is Diagu, and why does it matter so much to today’s hospitals?

Maintaining Standards of Care Amidst Unprecedented Challenges

As hospitals and other medical facilities continue to deal with the impact of COVID-19, they face challenges beyond the periodic scarcity of supplies and personnel. Many regions of the world have experienced a sort of rolling triage, with local outbreaks filling hospitals beyond capacity for weeks at a time. The pandemic has done more than tax our ability to deliver equipment, supplies, and personnel when and where they are needed: it has undercut the very suppositions on which our medical facilities were planned and built, and under which they had operated.

Hospital administrators have responded with tremendous resourcefulness, finding new ways to treat an unforeseeable flood of critically ill patients. Hospital personnel, especially front-line medical staff, have made heroic sacrifices to meet the challenge. But as the pandemic wears on and the possibility of new variants of the novel coronavirus looms, we must do even more. When every bit of space is being used wisely and hospital personnel are working beyond their limits, operational efficiencies may be the key to serving more patients during local outbreaks.

Some of those opportunities are specific to each hospital, and administrators have long since taken steps to address them. But others are at least partly beyond hospital administrators’ direct control. In vitro diagnostic testing, for example, is often conducted by third-party laboratories. All told, 14 billion diagnostic tests are administered each year in the US, where they support roughly 70% of all medical decisions.

However good the relationship between a given hospital and its laboratory partners, and however accustomed its medical staff has grown the ways in which a given lab reports test results, the traditional test-reporting process requires a good deal of additional work before test results can be translated into actionable diagnoses.

Enter Diagu: Deeply Enhanced Test Reports for Better Diagnostic Decisions

Diagu closes the gap with an AI-powered solution that places each test result in a rich, immediately usable context, with no additional time spent gathering crucial data. The company’s enhanced reporting solution supports the judgment of medical personnel, allowing doctors to make more accurate diagnoses, more quickly and with greater confidence.
The system gathers information about each patient’s medical history, known current conditions, medical regimen, and other factors. This information is prepared before test results become available.

As soon as the laboratory completes a test, Diagu’s solution adds a groundbreaking layer of contextual information. Test results are compared to a database of results from similar tests, and a wealth of anonymized data describing the pre-existing conditions, diagnoses, treatment protocols, and health outcomes of millions of other patients. DICOM files and x-rays also contribute to this rich data pool, which is refreshed daily through an international network of partners who perform a collected 60 million tests each year.

The system then produces a report that clearly describes the current patient’s condition and test results in the immediately usable context of similar cases. Diagu’s Test Results Analyzer presents the system’s findings on any computer, tablet, or smartphone, though a customizable graphical interface. The Analyzer’s powerful visualization tools allow doctors to immediately identify ways in which the current patient’s results and symptoms deviate from the norm, and allows them to chart the historical success of various possible diagnoses over time. For each possible diagnosis, doctors may examine the success of various therapies, including the effectiveness of each documented pharmaceutical regimens over time.

The result is an immediate and actionable presentation of data that doctors have traditionally spent crucial minutes and hours compiling. Diagu does not seek to supplant human judgment. Rather, the company supports doctors, nurses, and other hospital staff in doing what they do best, when every second of their time matters more than ever.

Benefits That Continue Over Time

Diagu continues to pay dividends even after patients are diagnosed. For example, quick and accurate diagnoses help limit inpatient time by supporting the quickest route to successful health outcomes. More accurate diagnosis also supports the efficient use of hospital resources. The CDC estimates that as many as 80,000 deaths per year are directly attributable to preventable diagnostic errors. That figure represents an extreme outcome, and only hints at the time, money, and resources spent on unnecessary treatment guided by misdiagnoses that could have been prevented with readier access to more information.

When those diagnostic errors come to light, hospitals face an array of challenges having nothing directly to do with delivering patient care. Insurance companies may seek to withhold payment, and lawsuits are an unfortunate fact of life for today’s hospitals. Those factors will not change any time soon, much as we all wish they would. But Diagu can help hospitals document an effective response to legal and insurance-related questions by demonstrating that diagnosing physicians consulted every possible source of information before arriving at their conclusions.

An Idea Whose Time has Come

AI and machine learning have entered the medical mainstream. Chatbots can now handle routine inquiries by physicians and route cases to appropriate specialists; predictive analytics facilitates everything from public health initiatives to personal health tracking. AI research and advisory company Emerj predicts that AI can save the US healthcare economy $150 billion by 2026.

Diagu extends the promise of machine learning to the very heart of medical practice. In-vitro diagnostic testing is a $85 billion business in the US alone. The hospitals and clinics that drive this market must get every ounce of value from such a significant investment. Diagu helps them do just that.

Zu Synal
Diagu
email us here

Source: EIN Presswire

On Friday Christine Ichim rollerbladed across San Francisco in a procession of fire engines to raise awareness for firefighter cancer prevention.

SAN FRANCISCO, CA, USA, October 17, 2021 /EINPresswire.com/ — Christine Ichim became the first woman to rollerblading across Canada for leukemia research. Twenty five years ago on October 15th, she completed her 5000 mile trek. On Friday she commemorated that achievement by rollerblading across San Francisco to raise awareness for firefighter cancer prevention.

“Research saves lives”, Ichim stated at a ceremony held at San Francisco Fire department headquarters after her skate across the city. “I know now in my heart of hearts that there is nothing that is impossible. Cancer is the number one cause of line of duty deaths in the fire service. It is just not fair that those who would put their lives on the line for us would have their own lives endangered by the insidious disease of cancer. We need to fight it with everything we have, because we can make a difference.”

Escorted by a relay of SFFD engines and ladder trucks from nine separate firehouses, Ichim proceeded from one end of the city to the other. Ichim started her commemorative skate at Ocean Beach, dipping her skates in the ocean to initiate the event. She proceeded to make her way across San Francisco on skates along with SFFD LT. Julie DeJarlais accompanying her on bicycle, and trailed by engines and other apparatus along the way. They rolled by nine firehouses to highlight their service and the existential threat to their personnel presented by cancer from toxic exposures in the workplace.

Once Ichim reached the department headquarters, she was greeted by Chief Jeanine Nicholson and members of the command staff, along with honored guests such as the Consul General of Canada Rana Sarkar and Tony Stefani, head of the San Francisco Firefighter’s Cancer Prevention Foundation.

Sarkar presented Ichim with a letter of appreciation from the government of Canada, and Stefani accepted the donations Ichim collected as a result of her fund-raising efforts.

Ichim, inspired by Terry Fox, embarked on her journey to give hope to her mother who had terminal leukemia. “I had promised her that I would fight for her until the end. When she was given six months to live, I put on a pair of rollerblades to skate across Canada to fund a clinical trial in immunotherapy. I skated to fund research. I skated to give her hope. I skated because I had promised her I would not sit and watch her die,” said Ichim.

Ichim began her scientific quest then and there, building a laboratory in the basement of the family home in Kitchener, Ontario when she was still in grade school and devoting her time and energy to learning more about the foe she was fighting.

When Ichim was 18 she conceived the idea of rollerblading across Canada to raise funds and awareness for leukemia research, and after lining up support from various community organizations and local firms she embarked on her journey from Victoria BC. Six months and 5000 miles later she rolled into St. John’s, Newfoundland, completing the epic voyage and raising over $165,000 for cancer research. Her mother lived long enough to see her daughter return home and hung in long enough for doctors to discover the miracle drug Gleevec that dramatically changed the course of the disease.

Inspired by the ability of research to save human lives, Ichim is now the founder and CEO of Florica Therapeutics, a biotech startup in San Francisco named after her mother. She wanted to commemorate the anniversary of her crossing of Canada by shining the spotlight on the scourge of cancer in the fire service.

“We visited the firefighters memorial in Sacramento. I looked at the names of fallen firefighters, whose names were carved in stone. I saw at least a dozen names of people I knew, coworkers, friends of mine, recruits whom were lost to cancer.” said Terry Hogue (ret.) Rescue Captain for SFFD and Ichim’s husband. “My eyes welled with tears to see that some of the people we had lost to cancer were people I had trained in the fire academy, the next generation that was suppose to take over for us.”

Ichim came to San Francisco to complete postdoctoral research at Lawrence Berkeley National Labs. “There are many great cities in the world but San Francisco is the city where dreams come true. San Francisco is also a leader in social justice, it is a place where voices are heard and where voices matter. Dreamers come here to change the world. I too am a dreamer, and I dream of the day where we can cure cancer,” said Ichim.

“We can make a difference. Every person matters. I remember every person who gave me a high-five, who honked for support, who made a donation. You matter, your donations matter, your advocacy matters. You are the hope for all these firefighters whose greatest threat to life is not fire but cancer.”

To donate: https://gofund.me/5e9c0ad3

About the San Francisco Firefighters Cancer Prevention Foundation

The San Francisco Firefighters Cancer Prevention Foundation is committed to the prevention and early detection of cancer and providing access to cutting edge care for active and retired members of the San Francisco Fire Department and their families. Our goals are based on scientific research, education, cancer screening and health navigation. Through this research and advocacy we aim to improve public health and end this threat of job-related cancer in the firefighter profession.

Terrance Hogue
Florica Therapeutics, Inc
email us here
+1 415-579-1586
Visit us on social media:
Facebook
Twitter

Source: EIN Presswire

PVH Corporation, formerly known as Phillips-Van Heusen, has chosen The M3 System developed by Global Infection Control Consultants LLC for Pandemic Protection.

NORTH MIAMI, FLORIDA, UNITED STATES OF AMERICA, October 17, 2021 /EINPresswire.com/ — PVH Corporation, formerly known as Phillips-Van Heusen has worked with its long-term consultant, Global Infection Control Consultants LLC, to deploy GICC LLC’s Nobel Prize Nominated technology to protect employees in the distribution facilities as well as 500+ retail outlets in the USA and overseas.
GICC LLC developed an organic based, chemical, drug and alcohol-free solution that was successfully tested against COVID-19 as well as numerous other pathogens and tested for efficacy in a USA CDC Approved laboratory. The product has been manually applied in applications around the world for over 15 years. Several years ago, Dr. Arthur V. Martin and Kevin M. Martin began conceptualizing, engineering and producing what is known as The M3 System^® for automatic, calculated product infusion in buildings to provide 24/7/365 protection.
The system works on what is known as The Brownian Theory of Motion. The Brownian Theory describes how particles such as pathogenic fungi, bacteria, yeasts and viruses move randomly about in the air we breathe. By developing a methodology to infuse billions of individual pathogen-killing molecules into the air which also move randomly they come in contact with pathogens and kill them.
The efficacy of the ground breaking technology far exceeds results produced by current technologies such as HEPA filters, UV (Ultraviolet Light) and Bipolar Ionization. PVH has been using our technology in more than 500 retail outlets in the USA and overseas to protect employees and visitors since 2012.
“Having designed and built Clean Rooms, Hospital Operating Suites and Bio-Safety Laboratories around the world for nearly 40 years my approach was to be able to control and or eliminate pathogens but do it more efficiently and more effectively than any current technology utilizing organic materials and methods” said Dr. Martin. “Lou Schwartz who has been the PVH Quality Control Specialist and I have worked together since 2012 when we traveled together to Hong Kong, Mainland China and Bangladesh solving critical pathogen contamination problems affecting productivity, contract worker health and profits. This cooperative effort by both our companies is intended to protect PVH employees and facilities and show the world that innovative, successfully employed technology is now available for everyone. PVH has been using our product technology in more than 500 retail outlets in the USA and overseas to protect employees and visitors.”
The technology is applicable to many venues. Schools can reduce absenteeism and kids can learn and thrive in a safe environment. Office buildings can reduce absenteeism related to respiratory issues which will increase productivity and reduce insurance costs by reducing medical visits. Religious facilities can welcome worshipers back and provide a safe indoor environment for them. Restaurants and retail facilities can provide healthy indoor conditions for patrons. Fear of litigation is reduced.
One of the most highly critical locations for this ground breaking technology is the medical environment. Secondary, nosocomial infections, in hospitals has been a serious problem from years. In May of 2021 the CDC finally recognized that the main problem with the spread of COVID-19 was not doorknobs and elevator buttons. It was, is and will continue to be the air we breathe. The average adult breathes as much as 25,000 liters of air/day and everything in it.
The M3 System^® technology takes direct aim at this problem and the results are proven.
Total identified pathogen count as a variety of ten, reduced to 5 in just 30 hours with the remaining five at 12% quantification of the original count.
Total pathogen air content in 650,000 Sq. Ft. facility reduced by 90% before all units became operational.
Total number of commercial building occupants in a Florida installation testing positive after extended contact with outside infected people……..Zero.
PVH Corporation with $7.1 billion in global revenue, more than 33,000 employees and a global presence in 40+ countries continues to embrace innovative, ground braking technologies for their own staff and employees but with an eye on sustainability and environmental awareness.

Arthur V. Martin Ph.D.
GICC LLC
+1 843-368-7063
email us here

The M3 System Pandemic Protection Unit

Source: EIN Presswire

International Spa & Beauty Awards announces global winners for year 2021

DUBAI, DUBAI, UNITED ARAB EMIRATES, October 17, 2021 /EINPresswire.com/ — International Spa & Beauty Awards is pleased to announce the winners of the Year 2021 for all 6 regions. The International Spa Award recognises and celebrates excellence in all aspects of the spa & Beauty industry around the world. These awards offer a unique opportunity to Hotel Spa, Independent spa, Beauty Salons around the globe to benchmark and showcase their unique achievements.

These awards have attracted attention from specialists, customers, local and international print. Electronic media and social media influencers in the spa and beauty industry are part of the interested team that will follow this award program. The international attention accorded to this year’s awards ceremony offers an excellent marketing platform for spas, beauties, and salons worldwide that are promoting their salons and Spa.

The International Spa & beauty Awards 2021 attracts nominees from 6 regions around the globe. These are the Americas, Africa, Asia, Europe, Middle East, and Oceania. Over 60 countries from these regions are represented in this year's prestigious spa and beauty awards. The nominees in the 2021 award program cover spas, spa destinations, wellness retreat, Hotel spa, day spa & beauty salon

The winners in this year’s program are selected after a rigorous and careful three-step process namely: a First level Jury Review, followed by Voting then a Final Jury Review. All members of the jury have been selected to reflect and ensure international best practices in spa and beauty awards. A whopping 150,000 voting points received in the year 2021 international spa & beauty awards.

International spa & beauty awards proudly announce the following winners for Year 2021.

Au Petit Soin,Delmas,Haiti – Best Day Spa in Haiti 2021
TIME FOR SPA,LUMIAR,Portugal – Best Day Spa 2021
New York Ayurveda & Panchakarma Cente,New York,United States – Best Ayurveda Wellness Spa in USA 2021
Ponha Aqui o Seu Pezinho,Lisbon,Portugal – Best Foot Spa & Reflexology 2021
THAI LOTUS SPA OÜ,Tallinn,Estonia – Best Thai Massage and Spa in Estonia 2021
Lillehammer SPA AS,Lillehammer,Norway – Best Day Spa and wellness Centre in Norway 2021
Pure Emporium Ltd,Herefordshire,United Kingdom – Best Beauty Salon in Herefordshire 2021
ZZ Day Spa INC,New York,United States – Best Day Spa in New York, USA 2021
Spa Soul at The Bodrum Edition,Bodrum,Turkey – Best Luxury Resort Spa in Turkey 2021
Earth and Skin,Australia – Best Luxury Day Spa in Australia 2021
La Villa Clemenceau,Bordeaux,France – Best Luxury Spa with Salon 2021
LANAI green nature SPA,Minden,Germany – Best Holistic Wellness Retreat 2021 , Best Green /Eco Spa in Germany 2021
Clinique La Prairie,Montreux,Switzerland – Best Destination Spa in Switzerland 2021, Best Wellness Retreat in Europe 2021
Allure Health and Med spa,Omaha,United States – Best Health and Medical Spa in United States 2021
Mirrors Beauty Lounge,Dubai,United Arab Emirates – Best Female Salon in Dubai 2021
Edilma Therapy,Cork City,Ireland – Best Spa Therapist in Ireland 2021
UNIQUE DAY SPA,Dublin,Ireland – Best Day Spa 2021
N Bar,Dubai,United Arab Emirates – Best Nail Salon in UAE 2021
The Lounge Spa,Dubai,United Arab Emirates – Best Luxury Day Spa in UAE 2021
Sisi therapy,Saint Paul's Bay,Malta – Best Beauty Salon 2021
Flow Thai Massage & SPA,Richmond,Canada – Best Luxury Spa & Wellness Centre 2021
The Massage Place,Santa Monica,United States – Best Day Spa in Santa Monica, United States 2021
The Bath House – Russian Banya,London,United Kingdom – Best Day Spa in London 2021
Green River Wellness,Rijeka,Croatia – Best New Wellness Centre 2021
Chutima Therapy,Brighton,United Kingdom – Best Thai Massage and Spa 2021
The Spa at Hilton Luxor Resort & Spa,Luxor,Egypt – Best Luxury Wellness Spa in Egypt 2021
Soul Senses Spa & Wellness,Dubai,United Arab Emirates – Best Day Spa in Dubai 2021 ,Best Hotel Spa in Dubai 2021
Cervo Mountain Resort,Switzerland – Best Holistic Spa in Switzerland 2021
1847 For Men,Dubai,United Arab Emirates – Best Male Salon in UAE 2021
eforea Spa at Hilton Salwa Beach Resort & Villa,Doha,Qatar – Best Luxury Destination Spa in Qatar 2021
Savanna Thai Massage,Calgary , Canada – Best Thai Spa in Calgary 2021
Radisson Blu Hotel Yerevan,Yerevan,Armenia – Best Hotel Spa in Armenia 2021
BOUDOIR Day Spa,Tokyo,Japan – Best Day Spa in Tokyo 2021
Ultima Gstaad Spa & Clinic,Gstaad,Switzerland – Best Luxury Hotel Spa & Wellness in Switzerland 2021
King and Queen Spa Inc. K,Vancouver ,Canada – Best Beauty Salon in Vancouver , Canada 2021
Medical Refresh Beauty & Health,Munich,Germany – Best Medical Beauty Salon in Germany 2021
Balance Ayurvedic Center & Spa owned by Landmark Group,Dubai,United Arab Emirates – Best Ayurveda Wellness Spa in Middle East 2021
Shine Spa by Sheraton,Chennai,India – Best Resort Spa in India 2021
Sindhorn Wellness by Resense, Kempinski Hotels,Bangkok,Thailand – Best New Luxury Hotel Spa in Thailand 2021
RADISSON BLU PALACE RESORT THALASSO & SPA DJERBA,Djerba,Tunisia – Best Destination Spa in Tunisia 2021
Te Aroha Mineral Spas,Te Aroha,New Zealand – Best Destination Spa in Oceania 2021
Mandala Wellness,Ho Chi Minh City,Vietnam – Best Wellness Centre in Vietnam 2021
Upper Village Spa,Toronto,Canada – Best Day Spa in Toronto 2021
YHI Spa,Ko Samui,Thailand – Best Luxury Resort Spa in Thailand 2021
Apurva Spa at The Apurva Kempinski Bali,Denpasar,Indonesia – Best Destination Spa in Indonesia 2021 ,Best Spa Team in Indonesia 2021
Semiramis Spa,Cairo,Egypt – Best Luxury Day Spa in Egypt 2021
sisters beauty lounge,Dubai,United Arab Emirates – Best Luxury Beauty Salon in UAE 2021 ,Best Female Salon in UAE 2021
Willow Stream Spa – Fairmont, The Palm Dubai,Dubai,United Arab Emirates – Best Luxury Resort Spa and Wellness in UAE 2021

International Spa Awards 2021 is Partnered with HotelApp – No.1 Guest Service Hotel app, TravelCEO – Leading Travel CRM software, Mr.Resto – Best Restaurant QR Menu app and it is organised by Golden Tree Events Dubai

Karthikaiselvam V
Golden Tree Events Dubai
+971 58 587 2014
email us here

Source: EIN Presswire

PORTLAND, OR, UNITED STATES, October 17, 2021 /EINPresswire.com/ — "DNA Sequencing Market by Product, Application, Technology, and End User: Global Opportunity Analysis and Industry Forecast, 2017 – 2025,"the global DNA sequencing market was valued at $6,243 million in 2017, and is projected to reach $25,470 million by 2025, growing at a CAGR of 19.0% from 2017 to 2025.

Technological advancements, increase in applications of DNA sequencing, rise in collaborations & partnerships, and rise in genome mapping programs drive the growth of the global DNA sequencing market. However, scarcity of skilled professionals and concerns related to standardization of DNA sequencing-based diagnostics hinder the market growth. On the other hand, acceptance of cloud computing as potential data management service along with untapped potential in emerging economies create new opportunities.

Explore Report Description@ https://www.alliedmarketresearch.com/dna-sequencing-market

Technological advancements, increase in applications of DNA sequencing, rise in collaborations & partnerships, and rise in genome mapping programs drive the growth of the global DNA sequencing market. However, scarcity of skilled professionals and concerns related to standardization of DNA sequencing-based diagnostics hinder the market growth. On the other hand, acceptance of cloud computing as potential data management service along with untapped potential in emerging economies create new opportunities.

"DNA Sequencing Market by Product, Application, Technology, and End User: Global Opportunity Analysis and Industry Forecast, 2017 – 2025,"the global DNA sequencing market was valued at $6,243 million in 2017, and is projected to reach $25,470 million by 2025, growing at a CAGR of 19.0% from 2017 to 2025.

Based on product, the consumables segment accounted for the highest market share in 2018, holding more than half of the global DNA sequencing market. This segment is estimated to maintain its dominant share during the forecast period. However, the platforms segment is expected to register at the highest CAGR of 22.0% from 2018 to 2025. The research also analyzes the services segment.

Based on application, the biomarkers and cancer segment contributed to the highest share in 2018, accounting for more than one-third of the market. However, the personalized medicine segment is expected to register the fastest CAGR of 26.7% from 2018 to 2025.

Based on technology, the sequencing by synthesis segment accounted for the largest share in 2018, accounting for more than one-fifth of the market, and is expected to maintain its dominance during the forecast period. However, the pyro sequencing segment is estimated to portray the highest CAGR of 27.2% during the forecast period.

On the basis of region, North America held more than two-fifths of the global DNA sequencing market and is estimated to maintain its lead position throughout the forecast period. However, Asia-Pacific is expected to witness the highest CAGR of 24.1% during the forecast period.

Inquiry For Buying@ https://www.alliedmarketresearch.com/purchase-enquiry/163

Leading market players analyzed in the report include Abbott Laboratories, Danaher Corporation (Beckman Coulter, Inc.), Agilent Technologies, Inc., Illumina, Inc., F. Hoffmann-La Roche Ltd., Pacific Biosciences of California, Inc., LI-COR Biosciences, Inc., PerkinElmer Inc., Siemens AG, and Thermo Fisher Scientific, Inc.

Avenue Basic Plan | Library Access | 1 Year Subscription |

Sign up for Avenue subscription to access more than 12,000+ company profiles and 2,000+ niche industry market research reports at $699 per month, per seat. For a year, the client needs to purchase minimum 2 seat plan.

Request for 14 days free trial: https://www.alliedmarketresearch.com/avenue/trial/starter

“We have also published few syndicated market studies in the similar area that might be of your interest. Below are the report title for your reference, considering Impact of Covid-19 Over This Market which will help you to assess aftereffects of pandemic on short-term and long-term growth trends of this market.”

Trending Reports in Healthcare Industry:

Blood Culture Test Market Global Research By 2030

Tissue Engineering Market Global Research By 2030

Diabetes Drugs Market Global Research By 2030

About Us:

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

Pawan Kumar, the CEO of Allied Market Research, is leading the organization toward providing high-quality data and insights. We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts

David Correa
Allied Analytics LLP
+18007925285 ext.
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn

Source: EIN Presswire

PORTLAND, OR, UNITED STATES, October 17, 2021 /EINPresswire.com/ — Pediatric ultrasound for cardiology, also known as echocardiograph, is done for attaining a complete view of congenital and acquired heart diseases in children. Echocardiographic evaluation gives detailed information of numerous lesions present in the pediatric heart. Ultrasound waves or sound waves are used to develop different images of heart, and a Doppler test is done to measure the speed and direction of blood flow

Asia-Pacific accounted for the highest share in the world pediatric ultrasound market for cardiology, and is expected to grow at a CAGR of 4.1%. This is attributable to the rising number of pediatric congenital and acquired heart diseases in the developing countries, such as India and China, and increasing awareness related to early detection of cardiac diseases

Explore Report Description@ https://www.alliedmarketresearch.com/ultrasound-market

The major factors boosting the market growth include technological advancements in ultrasound systems (such as 4D imaging capabilities incorporated in Vivid E95 cardiovascular ultrasound system), increase in incidence of cardiac diseases, and rise in public and private investments, grants, & funds for the development of more advanced ultrasound devices. In addition, increasing number of ultrasound diagnostic imaging procedures, rising demand for minimal invasive therapies, and growing awareness for early disease diagnosis are expected to drive the demand for pediatric cardiac ultrasound. Conversely, lack of skilled and experienced sonographers or pediatric cardiologists worldwide restrains the market growth.

These two tests are combined and used by the pediatric cardiologist or pediatric sonographer to learn aspects regarding the functioning of the heart and its anatomy. Echocardiography is the most common test used in children to diagnose or rule out heart disease, and also to follow children who have already been diagnosed with a heart problem. This test can be performed on children of all ages, including fetuses and newborns to adolescents.

Echocardiography is the most common test utilized to diagnose cardiac diseases, and also to follow children diagnosed with cardiac problem. Among all age groups, the adolescents (1319 years) group is the major segment, and is expected to exhibit the highest CAGR during the forecast period. This growth is mainly due to inactive lifestyle and obesity that leads to different acquired heart diseases in adolescents, which results into high use of echocardiogram.

The global pediatric ultrasound market for cardiology is segmented based on age group and region. Based on geography, pediatric ultrasound market for cardiology is studied with respect to four major regions, namely, North America (including U.S., Canada, and Mexico), Europe (including Germany, France, U.K. and Rest of Europe), Asia-Pacific (including Japan, China, India, and Rest of Asia-Pacific), and LAMEA (including Latin America, Middle East, and Africa). The report includes revenue generated from the sales of the aforementioned ultrasound devices. This study excludes revenue generated from post-sale services of the devices (after the expiration of contracts).

For Purchase Enquiry: https://www.alliedmarketresearch.com/purchase-enquiry/1713

The key players profiled in this report are General Electric Company, Koninklijke Philips N.V., Siemens AG, Samsung Medison Co. Ltd., Analogic Corporation, Esaote SpA, Fujifilm Corporation, Hitachi, Ltd., Mindray Medical International Limited, Samsung Medison Co. Ltd., and Toshiba Corporation.

Avenue Basic Plan | Library Access | 1 Year Subscription |

Sign up for Avenue subscription to access more than 12,000+ company profiles and 2,000+ niche industry market research reports at $699 per month, per seat. For a year, the client needs to purchase minimum 2 seat plan.

Request for 14 days free trial: https://www.alliedmarketresearch.com/avenue/trial/starter

“We have also published few syndicated market studies in the similar area that might be of your interest. Below are the report title for your reference, considering Impact of Covid-19 Over This Market which will help you to assess aftereffects of pandemic on short-term and long-term growth trends of this market.”

Trending Reports in Healthcare Industry:

Prostate Cancer Market Global Research By 2030

Apheresis Equipment Market Global Research By 2030

Diabetes Drugs Market Global Research By 2030

About Us:

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

Pawan Kumar, the CEO of Allied Market Research, is leading the organization toward providing high-quality data and insights. We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts

David Correa
Allied Analytics LLP
+18007925285 ext.
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn

Source: EIN Presswire

PORTLAND, OR, UNITED STATES, October 17, 2021 /EINPresswire.com/ — Increase in popularity of personalized medicines, growth in R&D expenditure, and technological advancements related to proteomics components fuel the global proteomics market. On the other hand, lack of skilled professionals and high costs related to proteomics components impede the growth to some extent. Nevertheless, biomarker identification and advancements in mass spectrometry-based proteomics are projected to create an array of opportunities in the coming years.

global Proteomics Market was pegged at $21.12 billion in 2019, and is anticipated to reach $49.97 billion by 2027, registering a CAGR of 12.2% from 2020 to 2027. The report provides an in-depth analysis of the top investment pockets, top winning strategies, drivers & opportunities, market size & estimations, competitive scenario, and varying market trends.

Explore Report Description@ https://www.alliedmarketresearch.com/press-release/proteomics-market.html

Covid-19 Scenarios-

– Proteomic technologies have helped in cognizing the profile of viral proteins that disturb respiratory pathways. Methods such as MS-based detection and RT-PCR are extensively being used to detect SARS-CoV-2 in individuals.

– At the same time, proteomics have also aided in revealing novel biomarkers and interpreting point-of-care procedures.

The global proteomics market is analyzed across component, application, and region. Based on component, the reagents segment contributed to more than three-fourths of the total market share in 2019 and would maintain its dominance by 2027. The instruments segment, on the other hand, is projected to register the fastest CAGR of 14.1% from 2020 to 2027.

Based on application, the drug discovery segment accounted for around three-fifths of the total market revenue in 2019, and would lead the trail by the end of 2027. Simultaneously, the disease diagnosis segment is anticipated to exhibit the fastest CAGR of 12.6% throughout the forecast period.

Based on region, the market across North America held the major share in 2019, garnering nearly two-fifths of the global proteomics market. At the same time, the Asia-Pacific region would manifest the fastest CAGR of 15.6 % from 2020 to 2027. The other two provinces studied in the report include Europe and LAMEA.

The key market players analyzed in the global proteomics market report include Danaher Corporation, General Electric (GE), LI-COR, Inc., Waters Corporation, Agilent Technologies Inc., PerkinElmer, Inc., HORIBA, Ltd., Bio-Rad Laboratories, Inc., Thermo Fisher Scientific, Inc., and Bruker Corporation. These market players have embraced several strategies including partnership, expansion, collaboration, joint ventures, and others to prove their flair in the industry.

For Purchase Enquiry: https://www.alliedmarketresearch.com/purchase-enquiry/1677

Avenue Basic Plan | Library Access | 1 Year Subscription |

Sign up for Avenue subscription to access more than 12,000+ company profiles and 2,000+ niche industry market research reports at $699 per month, per seat. For a year, the client needs to purchase minimum 2 seat plan.

Request for 14 days free trial: https://www.alliedmarketresearch.com/avenue/trial/starter

“We have also published few syndicated market studies in the similar area that might be of your interest. Below are the report title for your reference, considering Impact of Covid-19 Over This Market which will help you to assess aftereffects of pandemic on short-term and long-term growth trends of this market.”

Trending Reports in Healthcare Industry:

Prostate Cancer Market Global Research By 2030

Apheresis Equipment Market Global Research By 2030

Diabetes Drugs Market Global Research By 2030

About Us:

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

Pawan Kumar, the CEO of Allied Market Research, is leading the organization toward providing high-quality data and insights. We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts

David Correa
Allied Analytics LLP
+18007925285 ext.
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn

Source: EIN Presswire

Rise in incidents of chronic disease and technical advancement that have eased thawing drive the growth of the global medical thawing system market.

PORTLAND, OR, UNITED STATES, October 17, 2021 /EINPresswire.com/ — Rise in incidents of chronic disease, technical advancement that have eased thawing, increase in awareness and government initiative towards the plasma donation drive the growth of the global medical thawing system market. On the other hand, surge in launches and agreement of medical thawing and increase in number of embryo donors further fuel the growth. However, high cost of the automation restrains the market growth. Contrarily, growing need for new medicinal inventions to push adoption of thawing systems creates new opportunities in the next few years.

"Medical Thawing System Market by Sample Type (Blood, Embryo, Ovum, and Semen) and End User (Blood Banks, Hospitals, Tissue Banks, Pharmaceutical & Biotech Companies, and Others): Global Opportunity Analysis and Industry Forecast, 2020–2027." According to the report, the global medical thawing system market size garnered $165.82 million in 2019, and is projected to garner $279.17 million by 2027, registering a CAGR of 11.6% from 2020 to 2027.

Explore Report Description@ https://www.alliedmarketresearch.com/medical-thawing-system-market-A10559

Covid-19 Scenario

– Healthcare providers were instructed to focus on offering emergency healthcare to patients infected with coronavirus. The industry therefore, suspended certain activities.

– In addition, thawing played an important part in drug discovery and research & development during COVID-19 drugs/vaccine preparations.

The blood segment to maintain its leadership status during the forecast period

By sample type, the blood segment accounted for the highest market share, contributing to more than half of the global medical thawing system market in 2019, and is estimated to maintain its leadership status during the forecast period. This is due to increasing demand for blood and blood products and rising incidence of hemorrhage related events. However, the embryo segment is expected to manifest the highest CAGR of 12.4% from 2020 to 2027, owing to increase in pregnancy rate and live birth rate due to embryo donation. Furthermore, the increasing adoption of in vitro fertilization (IVF) treatment for infertility boosts the demand for advanced thawing systems.

The blood bank segment to maintain its dominance during the forecast period

Based on end user, the blood bank segment contributed to the largest market share in 2019, accounting for more than one-third of the global medical thawing system market, and is projected to maintain its dominance in terms of revenue during the forecast period. This is due to increase in dominance because of vast utilization of thawing systems in these transfusion centers and blood banks. Moreover, the tissue banks segment is projected to register the fastest CAGR of 13.1% from 2020 to 2027. Tissues banks are considered institutions that recover and store human cadaver tissues for medical studies and education. This drives the growth of the segment.

North America to maintain its lead position by 2027

By region, North America held the highest market share in 2019, accounting for nearly two-fifths of the global medical thawing system market, and is estimated to maintain its lead position by 2027. This is due to high rate of adoption, increase in awareness programs about blood donation and plasma donation. However, the Asia-Pacific region is projected to maintain the highest CAGR of 13.7% during the forecast period. Asia-Pacific have a large patient pool with a high incidence of chronic diseases. Which increases the demand for thawing systems.

For Purchase Enquiry: https://www.alliedmarketresearch.com/purchase-enquiry/10924

Leading Market Players:

Prominent players operating in the global medical thawing system market include Barkey GmbH & Co. KG, Boekel Scientific, BioLife Solutions Inc, Cardinal Health, Inc., General Electric Company, Helmer Scientific, Sartorius AG, Sarstedt AG & Co. KG, Terumo Corporation, and Thermo Fisher Scientific Inc. These players are adopting growth strategies such as product launches, mergers and acquisitions (M&As), product developments, and partnerships & collaborations to gain competitive advantage.

Avenue Basic Plan | Library Access | 1 Year Subscription |

Sign up for Avenue subscription to access more than 12,000+ company profiles and 2,000+ niche industry market research reports at $699 per month, per seat. For a year, the client needs to purchase minimum 2 seat plan.

Request for 14 days free trial: https://www.alliedmarketresearch.com/avenue/trial/starter

“We have also published few syndicated market studies in the similar area that might be of your interest. Below are the report title for your reference, considering Impact of Covid-19 Over This Market which will help you to assess aftereffects of pandemic on short-term and long-term growth trends of this market.”

Trending Reports in Healthcare Industry:

Prostate Cancer Market Global Research By 2030

Apheresis Equipment Market Global Research By 2030

Diabetes Drugs Market Global Research By 2030

About Us:

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

Pawan Kumar, the CEO of Allied Market Research, is leading the organization toward providing high-quality data and insights. We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts

David Correa
Allied Analytics LLP
8007925285 ext.
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn

Source: EIN Presswire

PORTLAND, OR, UNITED STATES, October 17, 2021 /EINPresswire.com/ — Rise in prevalence of autoimmune diseases and chronic respiratory conditions, advent of new drugs, and surge in adoption rate of anti-inflammatory drugs drive the growth of the global anti-inflammatory therapeutics market. However, side effects of anti-inflammatory drugs and patent expiration hinder the market growth. On the contrary, development of biosimilars for existing drugs is expected to open lucrative opportunities for the market players in the future.

global Anti-Inflammatory Therapeutics Market was accounted for $98.02 billion in 2020, and is estimated to hit $125.55 billion by 2028, growing at a CAGR of 4.0% from 2021 to 2028.

Explore Report Description@ https://www.alliedmarketresearch.com/anti-inflammatory-therapeutics-market

Covid-19 scenario:

– The Covid-19 pandemic positively affected the anti-inflammatory therapeutics market, as Covid-19 infection causes severe anti-inflammatory pneumonia, acute respiratory distress syndrome, multiple organ failure, and acute lung injury.

– The Covid-19 infection increased the investment in R&D for the treatment of inflammation in patients. Moreover, several clinical trials are underway to alleviate such inflammation in Covid-19 patients.

The report segments the global anti-inflammatory therapeutics market on the basis of drug class, indication, and region.

Based on drug class, the anti-inflammatory biologics segment held the lion’s share in 2020, accounting for nearly three-fifths of the market. Moreover, the segment is expected to register the highest CAGR of 4.3% during the forecast period. The research also analyzes the segments including nonsteroidal anti-inflammatory drugs (NSAIDs) and corticosteroids.

On the basis of indication, the Psoriasis segment would showcase the highest CAGR of 4.9% during the forecast period. However, the arthritis segment held the largest share in 2020, contributing to around two-fifths of the market.

For Purchase Enquiry: https://www.alliedmarketresearch.com/purchase-enquiry/286

The global anti-inflammatory therapeutics market is analyzed across several regions such as North America, Europe, Asia-Pacific, and LAMEA. The market across North America dominated in 2020, holding more than one-third of the market. However, the market across Asia-Pacific is expected to manifest the highest CAGR of 5.2% from 2021 to 2028.

The global anti-inflammatory therapeutics market report includes an in-depth analysis of the prime market players such as Abbvie, Inc., Pfizer, Inc., GlaxoSmithKline, Johnson & Johnson, Novartis, Merck & CO., Inc., La Roche AG, F. Hoffman, AstraZeneca PLC, Eli Lily and Company, and Amgen.'

Avenue Basic Plan | Library Access | 1 Year Subscription |

Sign up for Avenue subscription to access more than 12,000+ company profiles and 2,000+ niche industry market research reports at $699 per month, per seat. For a year, the client needs to purchase minimum 2 seat plan.

Request for 14 days free trial: https://www.alliedmarketresearch.com/avenue/trial/starter

“We have also published few syndicated market studies in the similar area that might be of your interest. Below are the report title for your reference, considering Impact of Covid-19 Over This Market which will help you to assess aftereffects of pandemic on short-term and long-term growth trends of this market.”

Trending Reports in Healthcare Industry:

Immunoassay Market Global Research By 2030

Closed MRI Systems Market Global Research By 2030

Hearing Aids Market Global Research By 2030

About Us:

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

Pawan Kumar, the CEO of Allied Market Research, is leading the organization toward providing high-quality data and insights. We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts

David Correa
Allied Analytics LLP
+18007925285 ext.
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn

Source: EIN Presswire